Page 26 - HIVMED_v21_i1.indb

Page 8 of 8 Guideline

9. Gertsch A, Michel O, Locatelli I, et al. Adherence to antiretroviral treatment 21. Phillips AN, Bansi-Matharu L, Venter F, et al. Updated assessment of risks and
decreases during postpartum compared to pregnancy: A longitudinal electronic benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in
monitoring study. AIDS Patient Care STDs. 2013;27(4):208–210. https://doi. sub-Saharan Africa: Modelling to inform treatment guidelines. Lancet HIV. Elsevier
org/10.1089/apc.2013.0005 BV; 2020;7(3):e193–e200. https://doi.org/10.1016/s2352-3018(19)30400-x
10. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during 22. WHO. Policy brief: Updated recommendations on first-line and second-line
and after pregnancy in low-income, middle-income, and high-income countries. AIDS. antiretroviral regimens and post-exposure prophylaxis and recommendations on
2012;26(16):2039–2052. https://doi.org/10.1097/qad.0b013e328359590f early infant diagnosis of HIV [homepage on the Internet]. Geneva: World Health
11. Haas A, Msukwa M, Egger M, et al. Adherence to antiretroviral therapy during and Organisation; 2018 [cited 2019 Sept 28]. Available from: https://www.who.int/
hiv/pub/guidelines/en/
after pregnancy: Cohort study on women receiving care in Malawi’s Option B+
Program. Clin Infect Dis. 2016;63(9):1227–1235. https://doi.org/10.1093/cid/ 23. Mofenson L. Web Annex C. Safety of dolutegravir in pregnancy and breastfeeding
ciw500 [homepage on the Internet]. In: Updated recommendations on first-line and
second-line antiretroviral regimens and post-exposure prophylaxis and
12. Henegar CE, Westreich DJ, Maskew M, Miller WC, Brookhart MA, Van Rie A. Effect of recommendations on early infant diagnosis of HIV: Interim guidelines. Supplement
pregnancy and the postpartum period on adherence to antiretroviral therapy to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating
amongst HIV-infected women established on treatment. JAIDS. 2015;68(4): 477–480. and preventing HIV infection. World Health Organisation; 2018 [cited 2019 Sept
https://doi.org/10.1097/qai.0000000000000501 28]. Available from: https://apps.who.int/iris/handle/10665/276491
13. Nieuwoudt SJ, Ngandu CB, Manderson L, Norris SA. Exclusive breastfeeding policy, 24. Waitt C, Orrell C, Walimbwa S, et al. Safety and pharmacokinetics of dolutegravir
practice and influences in South Africa, 1980 to 2018: A mixed-methods systematic in pregnant mothers with HIV infection and their neonates: A randomised trial
review. Doherty T, editor. PLoS One. 2019;14(10):e0224029. https://doi.org/ (DolPHIN-1 study). Mofenson LM, editor. PLoS Med. 2019;16(9):e1002895.
10.1371/journal.pone.0224029 https://doi.org/10.1371/journal.pmed.1002895
14. Rollins NC, Bhandari N, Hajeebhoy N, et al. Why invest, and what it will take to 25. SANDoH. National consolidated guidelines for the prevention of mother-to-child
improve breastfeeding practices? Lancet. Elsevier BV; 2016;387(10017):491–504. transmission of HIV (PMTCT) and the management of HIV in children, adolescents
https://doi.org/10.1016/s0140-6736(15)01044-2 and adults [homepage on the Internet]. South Africa National Department of
15. WHO, UNICEF. Guideline: Updates on HIV and infant feeding [homepage on the Health; 2015 [cited 2018 May]. Available from: https://www.health.gov.za/index.
Internet]. World Health Organisation; 2016 [cited 2019 Oct 17]. Available from: php/2014-03-17-09-09-38/policies-and-guidelines/category/230-2015p?
https://apps.who.int/iris/bitstream/10665/246260/1/9789241549707-eng.pdf download=937:national-art-guidelines-2015final
16. Myer L, Phillips T, McIntyre JA, et al. HIV viraemia and mother-to-child transmission 26. Abrams EJ, Myer L. Can we achieve an AIDS-free generation? Perspectives on
risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa. the global campaign to eliminate new pediatric HIV infections. JAIDS. 2013;
HIV Med; 2016;18(2):80–88. https://doi.org/10.1111/hiv.12397 63(Suppl 2):S208–S212. https://doi.org/10.1097/qai.0b013e3182986f55
17. Ewing AC, Ellington SR, Wiener JB, et al. Predictors of perinatal HIV transmission among 27. Myer L, Phillips TK. Beyond ‘Option B+’. JAIDS; 2017;75(1):S115–S122. https://doi.
women without prior antiretroviral therapy in a resource-limited setting. Pediatr Infect org/10.1097/qai.0000000000001343
Dis J. 2019;38(5):508–512. https://doi.org/10.1097/inf.0000000000002220 28. Bispo S, Chikhungu L, Rollins N, Siegfried N, Newell M-L. Postnatal HIV transmission
18. Khoo S. dolPHIN-1: Randomised controlled trial of dolutegravir (DTG)-versus in breastfed infants of HIV-infected women on ART: A systematic review and meta-
efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late analysis. JIAS. 2017;20(1):21251. https://doi.org/10.7448/ias.20.1.21251
pregnancy [homepage on the Internet]. Presented at: AIDS 2018 [cited 2019 Oct
18]. Available from: https://programme.aids2018.org/Abstract/Abstract/13144 29. Mancinelli S, Galluzzo CM, Andreotti M, et al. Virological response and drug
resistance 1 and 2 years post-partum in HIV-infected women initiated on life-long
19. Zash R, Holmes L, Diseko M, et al. Neural-tube defects and antiretroviral treatment antiretroviral therapy in Malawi. AIDS Res Hum Retroviruses. 2016;32(8):
regimens in Botswana. New Engl J Med. 2019;381(9):827–840. https://doi.org/ 737–742. https://doi.org/10.1089/aid.2015.0366
10.1056/NEJMoa1905230 30. Fogel J, Li Q, Taha TE, et al. Initiation of antiretroviral treatment in women after
20. WHO. Update of recommendations on first- and second-line antiretroviral delivery can induce multiclass drug resistance in breastfeeding HIV-infected
regimens [homepage on the Internet]. 2019 [cited 2019 Sept 29]. Available from: infants. Clin Infect Dis. 2011;52(8):1069–1076. https://doi.org/10.1093/cid/
https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en/ cir008

http://www.sajhivmed.org.za 18 Open Access